References and Notes
1a
Shimada Y.
Taniguchi N.
Matsuhisa A.
Sakamoto K.
Yatsu T.
Tanaka A.
Chem. Pharm. Bull.
2000,
48:
1644
1b
Kakefuda A.
Tsukada J.
Kusayama T.
Tahara A.
Tsukamoto Sh.
Bioorg. Med. Chem. Lett.
2002,
229
1c
Morita M.
Ohkubo-Suzuki A.
Takahashi T.
Nagashima A.
Sawada Y.
Ohkawa T.
Nishimura Sh.
Kita Y.
Drug Dev. Res.
2003,
60:
241
1d
Tsunoda T.
Yamazaki A.
Mase T.
Sakamoto Sh.
Org. Process Res. Dev.
2005,
9:
593
1e
Tsunoda T.
Yamazaki A.
Iwamoto H.
Sakamoto Sh.
Org. Process Res. Dev.
2003,
7:
883
1f
Matthews JM.
Greco MN.
Hecker LR.
Hoekstra WJ.
Andrade-Gordon P.
de Garavilla L.
Demarest KT.
Ericson E.
Gunnet JW.
Hageman W.
Look R.
Moore JB.
Maryanoff BE.
Bioorg. Med. Chem. Lett.
2003,
753
2a
Martinez A.
Castro A.
Dorronsoro I.
Alonso M.
Med. Res. Rev.
2002,
22:
373
2b
Zaharevitz DW.
Gussio R.
Leost M.
Senderowicz AM.
Lahusen T.
Kunick C.
Meijer L.
Sausville EA.
Cancer Res.
1999,
1:
60
2c
Schultz C.
Link A.
Leost M.
Zaharevitz DW.
Gussio R.
Sausville EA.
Meijer L.
Kunick C.
J. Med. Chem.
1999,
42:
2909
2d
Sielecki TM.
Boylan JF.
Benfield PA.
Trainor GL.
J. Med. Chem.
2000,
43:
2
2e
Kunick C.
Schultz C.
Lemcke T.
Zaharevitz DW.
Gussio R.
Jalluri RK.
Sausville EA.
Leost M.
Meijer L.
Bioorg. Med. Chem. Lett.
2000,
567
2f
Wieking K.
Knockaert M.
Leost M.
Zaharevitz DW.
Meijer L.
Kunick C.
Arch. Pharm. Pharm. Med. Chem.
2002,
7:
311
3a
Schoen WR.
Pisano JM.
Prendergast K.
Wyvratt MJ.
Fisher MH.
Cheng K.
Chan WW.-S.
Butler B.
Smith RG.
Ball RG.
J. Med. Chem.
1994,
37:
897
3b
DeVita RJ.
Wyvratt MJ.
Drugs Future
1996,
21:
273
3c
DeVita RJ.
Bochis R.
Frontier AJ.
Kotliar A.
Fisher MH.
Schoen WR.
Wyvratt MJ.
Cheng K.
Chan WW.-S.
Butler B.
Jacks TM.
Hickey GJ.
Schleim KD.
Leung K.
Chen Z.
Lee Chiu S.-H.
Feeney WP.
Cunningham PK.
Smith RG.
J. Med. Chem.
1998,
41:
1716
4a
Guzikowski AP.
Cai SX.
Espitia SA.
Hawkinson JE.
Huettner JE.
Nogales DF.
Tran M.
Woodward RM.
Weber E.
Keana JFW.
J. Med. Chem.
1996,
39:
4643
4b
Guzikowski AP.
Whittemore ER.
Woodward RM.
Weber E.
Keana JFW.
J. Med. Chem.
1997,
40:
2424
5a
Fray JM.
Cooper K.
Parry MJ.
Richardson K.
Steele J.
J. Med. Chem.
1995,
38:
3514
5b
Nagamatsu T.
Hantani Y.
Yamada M.
Sasaki K.
Ohtomo H.
Nakayama T.
Hirota T.
J. Heterocycl. Chem.
1993,
30:
193
5c
Nagamatsu T.
Hantani Y.
Sasaki K.
Ohtomo H.
Nakayama T.
Hirota T.
J. Heterocycl. Chem.
1993,
30:
233
6
Seto M.
Miyamoto N.
Aikawa K.
Aramaki Y.
Kansaki N.
Iizawa Y.
Baba M.
Shiraishi M.
Bioorg. Med. Chem.
2005,
13:
363
7
Ikemoto T.
Ito T.
Nishiguchi A.
Miura S.
Tomimatsu K.
Org. Process Res. Dev.
2005,
9:
168
8a
Fujita K.
Yamamoto K.
Yamaguchi R.
Org. Lett.
2002,
4:
2691
8b
Fujita K.
Takahashi Y.
Owaki M.
Yamamoto K.
Yamaguchi R.
Org. Lett.
2004,
6:
2785
9
Qadir M.
Priestley RE.
Rising TWDF.
Gelbrich T.
Coles SJ.
Hursthouse MB.
Sheldrake PW.
Whittall N.
Hii (Mimi) KK.
Tetrahedron Lett.
2003,
44:
3675
10
Omar-Amrani R.
Thomas A.
Brenner E.
Schneider R.
Fort Y.
Org. Lett.
2003,
5:
2311
11a
Qadir M.
Cobb J.
Sheldrake PW.
Whittall N.
White AJP.
Hii (Mimi) KK.
Horton PN.
Hursthouse MB.
J. Org. Chem.
2005,
70:
1545
11b
Dolman SJ.
Schrock RR.
Hoveyda AH.
Org. Lett.
2003,
5:
4899
12
Palma A.
Barajas JJ.
Kouznetsov VV.
Stashenko E.
Bahsas A.
Amaro-Luis JM.
Synlett
2004,
2721
13
Borch RF.
Bernstein MD.
Durst HD.
J. Am. Chem. Soc.
1971,
93:
2897
14
Anderson WK.
Lai G.
Synthesis
1995,
1287
15a
Hamer J.
Macaluso A.
Chem. Rev.
1964,
64:
473
15b
Kametani T.
Nagahara T.
Honda T.
J. Org. Chem.
1985,
50:
2327
15c
Mzengeza S.
Yang CM.
Whitney RA.
J. Am. Chem. Soc.
1987,
109:
276
15d
Mzengeza S.
Whitney RA.
J. Org. Chem.
1988,
53:
4074
15e
Varlamov A.
Kouznetsov V.
Zubkov F.
Chernyshev A.
Shurupova O.
Vargas L.
Palma A.
Rivero J.
Rosas A.
Synthesis
2002,
771
16
Murahashi S.-I.
Mitsui H.
Shiota T.
Tsuda T.
Watanabe S.
J. Org. Chem.
1990,
55:
1736
17 NMR data for exo-cycloadduct 4a: 1H NMR (400 MHz, CDCl3): δ = 2.58 (1 H, d, J = 16.5 Hz, 5-HA), 2.61-2.69 (2 H, m, 3-HAHB), 3.45 (1 H, dd, J = 16.6, 5.4 Hz, 5-HB), 4.62 (1 H, dd, J = 11.2, 4.4 Hz, 2-H), 4.97 (1 H, m, 4-H), 7.12 (1 H, dd, J = 6.6, 2.1 Hz, 9-H), 7.15-7.24 (3 H, m, 6-H, 7-H, 8-H), 7.30 (1 H, t, J = 7.6 Hz, 4′-H), 7.39 (2 H, t, J = 7.6 Hz, 3′-H, 5′-H), 7.50 (2 H, d, J = 7.2 Hz, 2′-H, 6′-H). 13C NMR (100 MHz, CDCl3): δ = 34.6 (5-C), 42.7 (3-C), 75.1 (4-C), 75.3 (2-C), 121.9 (9-C), 125.2 (5a-C), 125.9 (7-C), 126.4 (2′-C, 6′-C), 126.5 (8-C), 126.9 (4′-C), 128.4 (3′-C, 5′-C), 129.8 (6-C), 143.8 (1′-C), 150.9 (9a-C).
18 NMR data for cis-stereoisomer 5a: 1H NMR (400 MHz, CDCl3): δ = 2.14 (1 H, ddd, J = 11.0, 10.7, 10.5 Hz, 3-Hax), 2.22 (1 H, ddt, J = 11.0, 2.9, 1.9 Hz, 3-Heq), 3.03 (1 H, dt, J = 13.6, 1.9 Hz, 5-Heq), 3.13 (1 H, dd, J = 13.6, 10.5 Hz, 5-Hax), 3.88 (1 H, tdd, J = 10.5, 2.9, 1.9 Hz, 4-Hax), 3.98 (1 H, dd, J = 11.0, 1.9 Hz, 2-Hax), 6.70 (1 H, d, J = 7.6 Hz, 9-H), 6.92 (1 H, t, J = 7.6 Hz, 7-H), 7.10 (1 H, t, J = 7.6 Hz, 8-H), 7.18 (1 H, d, J = 7.6 Hz, 6-H), 7.35 (1 H, t, J = 6.9 Hz, 4′-H), 7.39 (2 H, d, J = 6.9 Hz, 2′-H, 6′-H), 7.43 (2 H, t, J = 6.9 Hz, 3′-H, 5′-H). 13C NMR (100 MHz, CDCl3): δ = 44.7 (5-C), 48.5 (3-C), 61.3 (2-C), 70.0 (4-C), 120.1 (9-C), 121.8 (7-C), 126.6 (2′-C, 6′-C), 127.4 (8-C), 127.8 (4′-C), 128.0 (5a-C), 128.9 (3′-C, 5′-C), 131.6 (6-C), 145.1 (1′-C), 149.4 (9a-C).